Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain
To compare coronavirus disease 2019 (COVID-19) hospitalization outcomes between persons with and without HIV. Retrospective observational cohort study in 150 hospitals in Spain. Patients admitted from 1 March to 8 October 2020 with COVID-19 diagnosis confirmed by severe acute respiratory syndrome co...
Saved in:
Published in: | AIDS (London) Vol. 36; no. 5; pp. 683 - 690 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Lippincott Williams & Wilkins
01-04-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | To compare coronavirus disease 2019 (COVID-19) hospitalization outcomes between persons with and without HIV.
Retrospective observational cohort study in 150 hospitals in Spain.
Patients admitted from 1 March to 8 October 2020 with COVID-19 diagnosis confirmed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 positive) PCR test in respiratory tract samples. The primary data source was the COVID-19 Sociedad Española de Medicina Interna's registry (SEMI-COVID-19). Demographics, comorbidities, vital signs, laboratory parameters, and clinical severity as well as treatments received during admission, treatment duration, ICU admission, use of invasive mechanical ventilation, and death were recorded. Factors associated with mortality and the composite of ICU admission, invasive mechanical ventilation, and death, were analyzed.
Data from 16 563 admissions were collected, 98 (0.59%) of which were of persons with HIV infection. These patients were younger, the percentage of male patients was higher, and their Charlson comorbidity index was also higher. Rates of mortality and composite outcome of ICU admission, invasive mechanical ventilation or death were lower among patients with HIV infection. In the logistic regression analysis, HIV infection was associated with an adjusted odds ratio of 0.53 [95% confidence interval (CI) 0.29-0.96] for the composite outcome.
HIV infection was associated with a lower probability of ICU admission, invasive mechanical ventilation, or death. |
---|---|
AbstractList | To compare coronavirus disease 2019 (COVID-19) hospitalization outcomes between persons with and without HIV.
Retrospective observational cohort study in 150 hospitals in Spain.
Patients admitted from 1 March to 8 October 2020 with COVID-19 diagnosis confirmed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 positive) PCR test in respiratory tract samples. The primary data source was the COVID-19 Sociedad Española de Medicina Interna's registry (SEMI-COVID-19). Demographics, comorbidities, vital signs, laboratory parameters, and clinical severity as well as treatments received during admission, treatment duration, ICU admission, use of invasive mechanical ventilation, and death were recorded. Factors associated with mortality and the composite of ICU admission, invasive mechanical ventilation, and death, were analyzed.
Data from 16 563 admissions were collected, 98 (0.59%) of which were of persons with HIV infection. These patients were younger, the percentage of male patients was higher, and their Charlson comorbidity index was also higher. Rates of mortality and composite outcome of ICU admission, invasive mechanical ventilation or death were lower among patients with HIV infection. In the logistic regression analysis, HIV infection was associated with an adjusted odds ratio of 0.53 [95% confidence interval (CI) 0.29-0.96] for the composite outcome.
HIV infection was associated with a lower probability of ICU admission, invasive mechanical ventilation, or death. OBJECTIVETo compare coronavirus disease 2019 (COVID-19) hospitalization outcomes between persons with and without HIV. DESIGNRetrospective observational cohort study in 150 hospitals in Spain. METHODSPatients admitted from 1 March to 8 October 2020 with COVID-19 diagnosis confirmed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 positive) PCR test in respiratory tract samples. The primary data source was the COVID-19 Sociedad Española de Medicina Interna's registry (SEMI-COVID-19). Demographics, comorbidities, vital signs, laboratory parameters, and clinical severity as well as treatments received during admission, treatment duration, ICU admission, use of invasive mechanical ventilation, and death were recorded. Factors associated with mortality and the composite of ICU admission, invasive mechanical ventilation, and death, were analyzed. RESULTSData from 16 563 admissions were collected, 98 (0.59%) of which were of persons with HIV infection. These patients were younger, the percentage of male patients was higher, and their Charlson comorbidity index was also higher. Rates of mortality and composite outcome of ICU admission, invasive mechanical ventilation or death were lower among patients with HIV infection. In the logistic regression analysis, HIV infection was associated with an adjusted odds ratio of 0.53 [95% confidence interval (CI) 0.29-0.96] for the composite outcome. CONCLUSIONHIV infection was associated with a lower probability of ICU admission, invasive mechanical ventilation, or death. |
Author | Martín-Escalante, María Dolores García-Alegría, Javier de Miguel-Campo, Borja Casas-Rojo, José Manuel Zurita-Etayo, María Alcalá-Pedrajas, José N. Rubio-Rivas, Manuel Arbones-Fernández, Laia Olalla-Sierra, Julián Roldán-Silvestre, Alicia Núñez-Cortés, Jesús Millán Cortés-Rodríguez, Begoña |
AuthorAffiliation | Internal Medicine Department, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona Internal Medicine Department, H. U. 12 de Octubre Internal Medicine Department, H. de Mataró. Barcelona Internal Medicine Department, H. Alto Guadalquivir, Andújar, Jaén Internal Medicine Department, H. de Pozoblanco, Córdoba Internal Medicine Department, Gregorio Marañón General University Hospital, Madrid, Spain Internal Medicine Department, Costa del Sol Hospital, Marbella (Málaga) Internal Medicine Department, Infanta Cristina University Hospital, Parla Internal Medicine Department, H. de Sagunto, Valencia Internal Medicine Department, H. U. Gregorio Marañón. Madrid |
AuthorAffiliation_xml | – name: Internal Medicine Department, H. de Mataró. Barcelona – name: Internal Medicine Department, H. U. Gregorio Marañón. Madrid – name: Internal Medicine Department, H. de Sagunto, Valencia – name: Internal Medicine Department, H. U. 12 de Octubre – name: Internal Medicine Department, H. de Pozoblanco, Córdoba – name: Internal Medicine Department, Costa del Sol Hospital, Marbella (Málaga) – name: Internal Medicine Department, Gregorio Marañón General University Hospital, Madrid, Spain – name: Internal Medicine Department, Infanta Cristina University Hospital, Parla – name: Internal Medicine Department, H. Alto Guadalquivir, Andújar, Jaén – name: Internal Medicine Department, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona |
Author_xml | – sequence: 1 givenname: Julián surname: Olalla-Sierra fullname: Olalla-Sierra, Julián organization: Internal Medicine Department, Costa del Sol Hospital, Marbella (Málaga) – sequence: 2 givenname: María Dolores surname: Martín-Escalante fullname: Martín-Escalante, María Dolores organization: Internal Medicine Department, Costa del Sol Hospital, Marbella (Málaga) – sequence: 3 givenname: Javier surname: García-Alegría fullname: García-Alegría, Javier organization: Internal Medicine Department, Costa del Sol Hospital, Marbella (Málaga) – sequence: 4 givenname: Manuel surname: Rubio-Rivas fullname: Rubio-Rivas, Manuel organization: Internal Medicine Department, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona – sequence: 5 givenname: Borja surname: de Miguel-Campo fullname: de Miguel-Campo, Borja organization: Internal Medicine Department, H. U. 12 de Octubre – sequence: 6 givenname: María surname: Zurita-Etayo fullname: Zurita-Etayo, María organization: Internal Medicine Department, H. U. Gregorio Marañón. Madrid – sequence: 7 givenname: Laia surname: Arbones-Fernández fullname: Arbones-Fernández, Laia organization: Internal Medicine Department, H. de Mataró. Barcelona – sequence: 8 givenname: José N. surname: Alcalá-Pedrajas fullname: Alcalá-Pedrajas, José N. organization: Internal Medicine Department, H. de Pozoblanco, Córdoba – sequence: 9 givenname: Alicia surname: Roldán-Silvestre fullname: Roldán-Silvestre, Alicia organization: Internal Medicine Department, H. de Sagunto, Valencia – sequence: 10 givenname: Begoña surname: Cortés-Rodríguez fullname: Cortés-Rodríguez, Begoña organization: Internal Medicine Department, H. Alto Guadalquivir, Andújar, Jaén – sequence: 11 givenname: José Manuel surname: Casas-Rojo fullname: Casas-Rojo, José Manuel organization: Internal Medicine Department, Infanta Cristina University Hospital, Parla – sequence: 12 givenname: Jesús Millán surname: Núñez-Cortés fullname: Núñez-Cortés, Jesús Millán organization: Internal Medicine Department, Gregorio Marañón General University Hospital, Madrid, Spain |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35323157$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkElPwzAQhS1URBf4Bwj5yCXFSxzHx6osrVQJIZYDl8hxHNWQ2sFOqODXky4sYi4zmnnvjfQNQc86qwE4xWiMkeAXd5PLMfpTFLHkAAxwzGnEGMc9MEAkEZGgHPXBMISXTsRQmh6BPmWUUMz4ADxPnXdWvhvfBliYoGXQkCAs4NKF2jSyMp-yMc5C1zbKrXSAxsJa--BsgGvTLKG0xXboBHA2f9rc72tp7DE4LGUV9Mm-j8Dj9dXDdBYtbm_m08kiUlSkIlJcyTxhnBUipTmjQpGS4ZSjnKpSyJxIxnORKl0UORNCSUV5kSApSMy1kgkdgfNdbu3dW6tDk61MULqqpNWuDRlJYpJ2JVgnjXdS5V0IXpdZ7c1K-o8Mo2xDNeuoZv-pdraz_Yc2X-nix_SN8Td37aqmY_NatWvts6WWVbPc5pEuKSKIEBQjjKLNStAvF82ECA |
CitedBy_id | crossref_primary_10_1016_j_jinf_2024_01_009 crossref_primary_10_1007_s11904_023_00647_z crossref_primary_10_1097_QAD_0000000000003200 crossref_primary_10_1016_j_ijid_2023_09_015 |
Cites_doi | 10.1016/S0140-6736(20)31189-2 10.1111/hiv.12911 10.1001/jama.2020.5394 10.1016/j.lfs.2020.117592 10.1016/S0140-6736(20)32013-4 10.1001/jamanetworkopen.2020.37069 10.1097/QAI.0000000000000954 10.1093/ofid/ofaa455 10.7326/M20-3689 10.1093/cid/ciaa880 10.46234/ccdcw2020.032 10.1097/QAI.0000000000002578 10.1016/j.rce.2020.07.003 10.1016/B978-0-12-407707-2.00002-3 10.1016/S2352-3018(20)30305-2 |
ContentType | Journal Article |
Copyright | Lippincott Williams & Wilkins Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
Copyright_xml | – notice: Lippincott Williams & Wilkins – notice: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
CorporateAuthor | SEMI-COVID-19 Network |
CorporateAuthor_xml | – name: SEMI-COVID-19 Network |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1097/QAD.0000000000003056 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-5571 |
EndPage | 690 |
ExternalDocumentID | 10_1097_QAD_0000000000003056 35323157 00002030-202204010-00009 |
Genre | Journal Article Observational Study |
GeographicLocations | Spain |
GeographicLocations_xml | – name: Spain |
GroupedDBID | --- .XZ .Z2 01R 0R~ 1J1 23M 2WC 354 40H 4Q1 4Q2 4Q3 5GY 5RE 5VS 71W 77Y 7O~ 85S 8L- AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAXQO ABASU ABBUW ABDIG ABIVO ABJNI ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFS ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ADBBV ADGGA ADHPY AE3 AE6 AEBDS AENEX AFDTB AFEXH AFSOK AFUWQ AGINI AHOMT AHQNM AHVBC AIJEX AINUH AJIOK AJNWD AJZMW AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BAWUL BOYCO BQLVK BYPQX C45 CS3 DIK DIWNM E.X E3Z EBS EEVPB ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OBH ODA ODMTH OHH OHYEH OJAPA OK1 OL1 OLB OLG OLH OLU OLV OLW OLY OLZ OPUJH OPX OVD OVDNE OVIDH OVLEI OVOZU OWU OWV OWW OWX OWY OWZ OXXIT P2P RIG RLZ S4R S4S SJN TEORI TR2 TSPGW V2I VVN W3M WOQ WOW X3V X3W XXN XYM YFH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3989-c7cab6575d983b539c2f51870b3cf9ab2a57b98ceddb599cac37d60a9247eca63 |
ISSN | 0269-9370 |
IngestDate | Fri Oct 25 01:37:03 EDT 2024 Fri Nov 22 03:06:01 EST 2024 Wed Oct 16 00:41:35 EDT 2024 Thu Nov 14 18:59:08 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3989-c7cab6575d983b539c2f51870b3cf9ab2a57b98ceddb599cac37d60a9247eca63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://doi.org/10.1097/qad.0000000000003056 |
PMID | 35323157 |
PQID | 2642888895 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2642888895 crossref_primary_10_1097_QAD_0000000000003056 pubmed_primary_35323157 wolterskluwer_health_00002030-202204010-00009 |
PublicationCentury | 2000 |
PublicationDate | 2022-April-1 2022-04-01 2022-04-1 20220401 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-April-1 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | AIDS (London) |
PublicationTitleAlternate | AIDS |
PublicationYear | 2022 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | 35323159 - AIDS. 2022 Apr 1;36(5):749-750 Sigel (R8-20240815) 2020; 71 Lederman (R11-20240815) 2013; 119 Del Amo (R14-20240815) 2020; 173 Cooper (R9-20240815) 2020; 21 Patel (R17-20240815) 2021; 86 Elfiky (R13-20240815) 2020; 253 Casas-Rojo (R16-20240815) 2020; 220 Grasselli (R4-20240815) 2020; 323 Bhaskaran (R7-20240815) 2021; 8 Ayerdi (R15-20240815) 2020; 7 Cummings (R3-20240815) 2020; 395 So-Armah (R12-20240815) 2016; 72 Tesoriero (R10-20240815) 2021; 4 (R2-20240815) 2020; 2 Geretti (R6-20240815) 2020 Boulle (R5-20240815) 2020 Group (R18-20240815) 2020; 396 |
References_xml | – volume: 395 start-page: 1763 year: 2020 ident: R3-20240815 article-title: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)31189-2 contributor: fullname: Cummings – volume: 21 start-page: 567 year: 2020 ident: R9-20240815 article-title: Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review publication-title: HIV Med doi: 10.1111/hiv.12911 contributor: fullname: Cooper – volume: 323 start-page: 1574 year: 2020 ident: R4-20240815 article-title: Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy publication-title: JAMA doi: 10.1001/jama.2020.5394 contributor: fullname: Grasselli – volume: 253 start-page: 117592 year: 2020 ident: R13-20240815 article-title: Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study publication-title: Life Sci doi: 10.1016/j.lfs.2020.117592 contributor: fullname: Elfiky – volume: 396 start-page: 1345 year: 2020 ident: R18-20240815 article-title: Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial publication-title: Lancet doi: 10.1016/S0140-6736(20)32013-4 contributor: fullname: Group – start-page: ciaa1198 year: 2020 ident: R5-20240815 article-title: Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa publication-title: Clin Infect Dis contributor: fullname: Boulle – start-page: ciaa1605 year: 2020 ident: R6-20240815 article-title: Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study publication-title: Clin Infect Dis contributor: fullname: Geretti – volume: 4 start-page: e2037069 year: 2021 ident: R10-20240815 article-title: COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2020.37069 contributor: fullname: Tesoriero – volume: 72 start-page: 206 year: 2016 ident: R12-20240815 article-title: Do biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between HIV infected and uninfected people? publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000000954 contributor: fullname: So-Armah – volume: 7 start-page: ofaa455 year: 2020 ident: R15-20240815 article-title: Preventive efficacy of tenofovir/emtricitabine against severe acute respiratory syndrome coronavirus 2 among pre-exposure prophylaxis users publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofaa455 contributor: fullname: Ayerdi – volume: 173 start-page: 536 year: 2020 ident: R14-20240815 article-title: Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study publication-title: Ann Intern Med doi: 10.7326/M20-3689 contributor: fullname: Del Amo – volume: 71 start-page: 2933 year: 2020 ident: R8-20240815 article-title: Coronavirus 2019 and people living with human immunodeficiency virus: outcomes for hospitalized patients in New York City publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa880 contributor: fullname: Sigel – volume: 2 start-page: 113 year: 2020 ident: R2-20240815 article-title: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 publication-title: China CDC Weekly doi: 10.46234/ccdcw2020.032 – volume: 86 start-page: 224 year: 2021 ident: R17-20240815 article-title: Clinical outcomes and inflammatory markers by hiv serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000002578 contributor: fullname: Patel – volume: 220 start-page: 480 year: 2020 ident: R16-20240815 article-title: Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry publication-title: Rev Clin Esp doi: 10.1016/j.rce.2020.07.003 contributor: fullname: Casas-Rojo – volume: 119 start-page: 51 year: 2013 ident: R11-20240815 article-title: Residual immune dysregulation syndrome in treated HIV infection publication-title: Adv Immunol doi: 10.1016/B978-0-12-407707-2.00002-3 contributor: fullname: Lederman – volume: 8 start-page: e24 year: 2021 ident: R7-20240815 article-title: HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform publication-title: Lancet HIV doi: 10.1016/S2352-3018(20)30305-2 contributor: fullname: Bhaskaran |
SSID | ssj0005088 |
Score | 2.454509 |
Snippet | To compare coronavirus disease 2019 (COVID-19) hospitalization outcomes between persons with and without HIV.
Retrospective observational cohort study in 150... OBJECTIVETo compare coronavirus disease 2019 (COVID-19) hospitalization outcomes between persons with and without HIV. DESIGNRetrospective observational cohort... |
SourceID | proquest crossref pubmed wolterskluwer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 683 |
SubjectTerms | COVID-19 - therapy COVID-19 Testing HIV Infections - complications Hospitalization Humans Intensive Care Units Male Retrospective Studies SARS-CoV-2 Spain - epidemiology |
Title | Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain |
URI | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00002030-202204010-00009 https://www.ncbi.nlm.nih.gov/pubmed/35323157 https://search.proquest.com/docview/2642888895 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpB2NljF277IYGewti8UVy9BgadylrO7akUPZiZFlmYcMucd39_Z1jyZe2e-ge5gfjSCCBzpdz0bkR8sGEjVo6Y0bojIUpl0xNc8HMLPeyXAkV5ujRXa6i0_PZIg7j0aht3dWP_VdKwxjQGjNn_4Ha3aIwAN9Ac3gD1eF9J7ofYEkCdbXZ1lXrfZmA-JWTH65DiEu8nJT1JexvXBw56t2DTDf8wIjlJViHML-6UK5Cd1uw9mixGnYDGVzW4s08W4G03aouARu98V4HQyxd0AwtChZXGoMrbZM-mLDjChT7X-W2j2_8BFRyU2yOnTLcDxvoi7K98xzV6aZk3zZXNlPtRBW1ywpwdxtgFvchMcby4zAKGOe2S0vLsG3FFAdMPuC-wvbEcYJc2D6kt2SErT38db6wtSvdg6ZULxPbOIDTL8nh2fFxso7P1zvkng_crLHbjz73cUTAp9ucTBl9_Nu613WeW4bMHnn4u8TYiOpnkxoxUHDWj8kjZ5nQuYXUEzIyxVNy_8TFXjwj3wfIog5ZFJFFbyCLtsiim4I6ZFEEFAVkUYcsCsjC-QZZz8nZYbw-WDLXmYPpAGPsdKRVii67TM6ClAdS-zn3gPWngc6lSn3Fo1TOtMky-PdLrXQQZWKqwNiPjFYieEF2i7IwLwkFlRvYghcIvFjjUigPlprKjEsj8igVY8Las0subAGWpA2cgLNObp71mLxvDzgBTonuL1WYsq4SH01teCQfk3178t2KAQ_A0OER7HaNFInNRm528WF9higFuec15Rim8tUddntNHvTYfkN2L7e1eUt2qqx-1yDpD4jvmHU |
link.rule.ids | 315,782,786,27933,27934,64549,64569,65344,65364 |
linkProvider | Flying Publisher |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwELZgKwEV4lWgy9NIKLeUJF478WEPYR9soV2BsoWWS-Q4jlghJatmU_4-M04CFMSBC74kki0n0UzsGX_fzBDy0oysWRq5RujcHWVcusorhGuiws8LJdSoQER3kYTL02g6wzQ5PVcVg8_qzQFe7DKNN1gOB_3C1fht4ixnn5Jx6UySyfjMeR-_mdljaiRJONNxdVFsnXhp6VcBaC-oQBCAlvo2eBrD_HYEZ2I0IDvxfLp6_ZML4tkCleCPSBf2a6-PsZPhqw_xtM1x2DU0uS_vYX8Yprvk5rcKse76q6W6_7JhzW__p0-9Q251Fi2NWxW8S66Y8h65dtxh9nvk8wSTJKiL9XlT0w4PomAQSPqlq1nShYLSqtnCK5qarku6sZ5ATfGcmKoytzcwgC4OP2J_slHr8j45mc9Wk4XbVXRwNUNulg61yhDqyWXEMs6kDgruw5KRMV1IlQWKh5mMtMlz0BqplWZhLjwFTmJotBLsARmUVWn2CQVTDdTJZwIPZLgUyoepPJlzaUQRZmJI3F5G6aZN3JH2gDvINP1dpkPyohdkCn8YwiaqNFVTpwG6aNAkH5KHrYR_zMg4AwOZh_C0SyJP2yjW9G_iefSP45-T64vV8VF6dLh895jcwN6WPvSEDLbnjXlKrtZ586zT6-9Mdvya |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwELaglSoQ4v3Y8jISyi0liddOfMghyu6yCyUqSqGFS-Q4jlghJatmU9R_z0weQEEcuOBLLNlyEn1je8bfzJiQl2baqaWBbYQu7GnOpa2cUtgmKN2iVEJNS2R0l6mfnAazOabJGRl8DD5rNgf46JZprOB1OGgXHodvUitO4_CTlcxP0jCxjqLX8-6YGp0krKPZIrywZmF9Xm6tKOmcsDyQYRAEzwNZdbsQagz228U0VjAFdqN4dbj66RHidNdUglUibdi1nTHSTvqv3kezPtPhUFDxvryT_aGeXic3vtXIeDdfO4f3X7atxa3_-sO3yc1Bu6VRL453yBVT3SV77wb-_h75HGPCBHW-PmsbOnBDFJQDSb8M95cMYaG0brfwoaah64puOqugoXhmTFVVdBXoQJerj9iebtS6uk8-LObH8dIebnewNUM_Le1rlSPtU8iA5ZxJ7ZXcheUjZ7qUKvcU93MZaFMUIEFSK838QjgKDEbfaCXYA7JT1ZV5RCiobSBaLhN4OMOlUC4M5ciCSyNKPxcTYo9IZZs-iUc2ku-AbPY7shPyYoQzg9mGFIqqTN02mYfmGhTJJ-Rhj_OPERlnoCxzH952Cfisj2jN_gbP_j_2f072APnscJW8fUyuYWPvSfSE7GzPWvOUXG2K9tkg3N8Bz1L_fA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronavirus+disease+2019+hospitalization+outcomes+in+persons+with+and+without+HIV+in+Spain&rft.jtitle=AIDS+%28London%29&rft.au=Olalla-Sierra%2C+Juli%C3%A1n&rft.au=Mart%C3%ADn-Escalante%2C+Mar%C3%ADa+Dolores&rft.au=Garc%C3%ADa-Alegr%C3%ADa%2C+Javier&rft.au=Rubio-Rivas%2C+Manuel&rft.date=2022-04-01&rft.eissn=1473-5571&rft.volume=36&rft.issue=5&rft.spage=683&rft.epage=690&rft_id=info:doi/10.1097%2FQAD.0000000000003056&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-9370&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-9370&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-9370&client=summon |